CCDC110 and hepatocellular carcinoma: In another multi-panel approach [46], auto-antibodies against 17 tumor antigens (p53, RalA, HSP70, Galectin1, KM-HN-1, NY-ESO-1, p90, Sui1, HSP40, Cyclin B1, HCC-22-5, c-myc, PrxVI, VEGF, HCA25a, p62, and Annexin) were evaluated for their association with colorectal cancer.